Literatur
- 1
A trial of preoperative radiotherapy in the management of operable rectal cancer.
Br J Surg.
1982;
69
513-519
- 2
The evaluation of low dose pre-operative X-ray therapy in the management of
operable rectal cancer: results of a randomly controlled trial.
Br J Surg.
1984;
71
21-25
- 3
Prolongation of the disease-free interval in surgically treated rectal carcinoma:
Gastrointestinal Tumor Study Group.
N Engl J Med.
1985;
312
1465-1472
- 4
Stockholm Rectal Cancer Study Group .
Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective
randomized trial.
Cancer.
1990;
66
49-55
- 5
Swedish Rectal Cancer Trial .
Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy
compared with operation alone in resectable rectal carcinoma.
Eur J Surg.
1996;
162
397-402
- 6
Randomised trial of surgery alone versus radiotherapy followed by surgery for
potentially operable locally advanced rectal cancer. Medical Research Council
Rectal Cancer Working Party.
Lancet.
1996;
348
1605-1610
- 7
Stockholm Colorectal Cancer Study Group .
Randomized study on preoperative radiotherapy in rectal carcinoma.
Ann Surg Oncol.
1996;
3
423-430
- 8
Swedish Rectal Cancer Trial .
Improved survival with preoperative radiotherapy in resectable rectal cancer.
N Engl J Med.
1997;
336
980-987
- 9
Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients
from 22 randomised trials.
Lancet.
2001;
358
1291-1304
- 10
Arnaud J P, Nordlinger B, Bosset J F, Boes G H, Sahmoud T, Schlag P M, Pene F.
Radical surgery and postoperative radiotherapy as combined treatment in rectal
cancer. Final results of a phase III study of the European Organization for
Research and Treatment of Cancer.
Br J Surg.
1997;
84
352-357
- 11
Brown G, Kirkham A, Williams G T, Bourne M, Radcliffe A G, Sayman J, Newell R, Sinnatamby C,
Heald R J.
High-resolution MRI of the anatomy important in total mesorectal excision of
the rectum.
AJR Am J Roentgenol.
2004;
182
431-439
- 12 Buchler M W, Heald R J, Maurer C A, Ulrich B C. Rektumkarzinom: Das Konzept der
Totalen Mesorektalen Exzision. Basel, Karger 1998
- 13
Bujko K, Kepka L. In regard to Marijnen et al .
Does radiotherapy compensate for a positive resection margin in rectal cancer
patients? IJROBP 2003;55:1311 - 1320.
Int J Radiat Oncol Biol Phys.
2003;
57
1199-1200
- 14
Bujko K, Nasierowska-Guttmejer A, Nowacki M P, Wojnar A, Chmielik E, Majewski P, Sygut J,
Karmolinski A, Husarski T, Szudrowicz Z, Kepka L.
Intramural distal spread of rectal cancer following preoperative radiotherapy:
the results of a multicentre randomized clinical study.
Int J Radiat Oncol Biol Phys.
2003;
57
S180
- 15
Dahl O, Horn A, Morild I, Halvorsen J F, Odland G, Reinertsen S, Reisaeter A, Kavli H,
Thunold J.
Low-dose preoperative radiation postpones recurrences in operable rectal cancer.
Results of a randomized multicenter trial in western Norway.
Cancer.
1990;
66
2286-2294
- 16
Dahlberg M, Glimelius B, Pahlman L.
Improved survival and reduction in local failure rates after preoperative radiotherapy:
evidence for the generalizability of the results of Swedish Rectal Cancer Trial.
Ann Surg.
1999;
229
493-497
- 17
Douglass H O, Moertel C G, Mayer R J, Thomas P R, Lindblad A S, Mittleman A, Stablein D M,
Bruckner H W.
Survival after postoperative combination treatment of rectal cancer.
N Engl J Med.
1986;
315
1294-1295
- 18
Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham D L, Fisher E R,
Caplan R, Jones J, Lerner H.
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer:
results from NSABP protocol R-01.
J Natl Cancer Inst.
1988;
80
21-29
- 19
Francois Y, Nemoz C J, Baulieux J, Vignal J, Grandjean J P, Partensky C, Souquet J C,
Adeleine P, Gerard J P.
Influence of the interval between preoperative radiation therapy and surgery
on downstaging and on the rate of sphincter-sparing surgery for rectal cancer:
the Lyon R90 - 01 randomized trial.
J Clin Oncol.
1999;
17
2396
- 20
Frykholm G J, Glimelius B, Pahlman L.
Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final
treatment results of a randomized trial and an evaluation of late secondary
effects.
Dis Colon Rectum.
1993;
36
564-572
- 21
Frykholm G J, Sintorn K, Montelius A, Jung B, Pahlman L, Glimelius B.
Acute lumbosacral plexopathy during and after preoperative radiotherapy of rectal
adenocarcinoma.
Radiother Oncol.
1996;
38
121-130
- 22
Gerard A, Berrod J L, Pene F, Loygue J, Laugier A, Bruckner R, Camelot G, Arnaud J P,
Metzger U, Buyse M.
Interim analysis of a phase III study on preoperative radiation therapy in resectable
rectal carcinoma. Trial of the Gastrointestinal Tract Cancer Cooperative Group
of the European Organization for Research on Treatment of Cancer (EORTC).
Cancer.
1985;
55
2373-2379
- 23
Gerard A, Buyse M, Nordlinger B, Loygue J, Pene F, Kempf P, Bosset J F, Gignoux M,
Arnaud J P, Desaive C.
Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results
of a randomized study of the European Organization for Research and Treatment
of Cancer (EORTC).
Ann Surg.
1988;
208
606-614
- 24
Glimelius B.
Chemoradiotherapy for rectal cancer ( is there an optimal combination?.
Ann Oncol.
2001;
12
1039-1045
- 25
Glimelius B, Pahlman L.
Perioperative radiotherapy in rectal cancer.
Acta Oncol.
1999;
38
23-32
- 26
Goldberg P A, Nicholls R J, Porter N H, Love S, Grimsey J E.
Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative
radiotherapy for rectal cancer: reduction in local treatment failure.
Eur J Cancer.
1994;
30A
1602-1606
- 27
Heald R J, Husband E M, Ryall R D.
The mesorectum in rectal cancer surgery ( the clue to pelvic recurrence?.
Br J Surg.
1982;
69
613-616
- 28
Heald R J, Ryall R D.
Recurrence and survival after total mesorectal excision for rectal cancer.
Lancet.
1986;
1
1479-1482
- 29
Hermanek P, Wiebelt H, Staimmer D, Riedl S.
Prognostic factors of rectum carcinoma ( experience of the German Multicentre
Study SGCRC. German Study Group Colo-Rectal Carcinoma.
Tumori.
1995;
81
60-64
- 30
Horn A, Halvorsen J F, Dahl O.
Preoperative radiotherapy in operable rectal cancer.
Dis Colon Rectum.
1990;
33
823-828
- 31
Hyams D M, Mamounas E P, Petrelli N, Rockette H, Jones J, Wieand H S, Deutsch M, Wickerham L,
Fisher B, Wolmark N.
A clinical trial to evaluate the worth of preoperative multimodality therapy
in patients with operable carcinoma of the rectum: a progress report of National
Surgical Breast and Bowel Project Protocol R-03.
Dis Colon Rectum.
1997;
40
131-139
- 32
Kapiteijn E, Marijnen C A, Nagtegaal I D, Putter H, Steup W H, Wiggers T, Rutten H J,
Pahlman L, Glimelius B, van Krieken J H, Leer J W, van de Velde C J.
Preoperative radiotherapy combined with total mesorectal excision for resectable
rectal cancer.
N Engl J Med.
2001;
345
638-646
- 33
Kockerling F, Reymond M A, Altendorf-Hofmann A, Dworak O, Hohenberger W.
Influence of surgery on metachronous distant metastases and survival in rectal
cancer.
J Clin Oncol.
1998;
16
324-329
- 34
Krook J E, Moertel C G, Gunderson L L, Wieand H S, Collins R T, Beart R W, Kubista T P,
Poon M A, Meyers W C, Mailliard J A.
Effective surgical adjuvant therapy for high-risk rectal carcinoma.
N Engl J Med.
1991;
324
709-715
- 35
Kwok H, Bissett I P, Hill G L.
Preoperative staging of rectal cancer.
Int J Colorectal Dis.
2000;
15
9-20
- 36
Letschert J G, Lebesque J V, de Boer R W, Hart A A, Bartelink H.
Dose-volume correlation in radiation-related late small-bowel complications:
a clinical study.
Radiother Oncol.
1990;
18
307-320
- 37
Marijnen C A, Kapiteijn E, van de Velde C J, Martijn H, Steup W H, Wiggers T, Kranenbarg E K,
Leer J W.
Acute side effects and complications after short-term preoperative radiotherapy
combined with total mesorectal excision in primary rectal cancer: report of
a multicenter randomized trial.
J Clin Oncol.
2002;
20
817-825
- 38
Marsh P J, James R D, Schofield P F.
Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results
of a prospective, randomized trial.
Dis Colon Rectum.
1994;
37
1205-1214
- 39
Maurer C A, Z’graggen K, Renzulli P, Schilling M K, Netzer P, Buchler M W.
Total mesorectal excision preserves male genital function compared with conventional
rectal cancer surgery.
Br J Surg.
2001;
88
1501-1505
- 40
Minsky B D.
Adjuvant therapy for rectal cancer ( a good first step.
N Engl J Med.
1997;
336
1016-1017
- 41
Moertel C G, Childs D S, Reitemeier R J, Colby M Y, Holbrook M A.
Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable
gastrointestinal cancer.
Lancet.
1969;
2
865-867
- 42
Molls M.
Pre- and postoperative radiotherapy with and without chemotherapy in rectal
cancer.
Chirurg.
1994;
65
569-575
- 43
O’Connell M J, Martenson J A, Wieand H S, Krook J E, Macdonald J S, Haller D G, Mayer R J,
Gunderson L L, Rich T A.
Improving adjuvant therapy for rectal cancer by combining protracted-infusion
fluorouracil with radiation therapy after curative surgery.
N Engl J Med.
1994;
331
502-507
- 44
Overgaard M, Bertelsen K, Dalmark M, Gadeberg C C, von der Maase H, Overgaard J,
Sell A.
A randomized feasibility study evaluating the effect of radiotherapy alone or
combined with 5-fluorouracil in the treatment of locally recurrent or inoperable
colorectal carcinoma.
Acta Oncol.
1993;
32
547-553
- 45
Pahlman L, Glimelius B.
Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report
from a randomized multicenter trial.
Ann Surg.
1990;
211
187-195
- 46
Pahlman L, Glimelius B, Graffman S.
Pre- versus postoperative radiotherapy in rectal carcinoma: an interim report
from a randomized multicentre trial.
Br J Surg.
1985;
72
961-966
- 47
Rider W D, Palmer J A, Mahoney L J, Robertson C T.
Preoperative irradiation in operable cancer of the rectum: report of the Toronto
trial.
Can J Surg.
1977;
20
335-338
- 48
Rodel C, Hohenberger W, Sauer R.
Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status.
Strahlenther Onkol.
1998;
174
497-504
- 49
Rominger C J, Gunderson L L, Gelber R D, Conner N.
Radiation therapy alone or in combination with chemotherapy in the treatment
of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic
recurrence following colorectal surgery. Radiation Therapy Oncology Group study
(76 - 16).
Am J Clin Oncol.
1985;
8
118-127
- 50
Sauer R.
Adjuvant versus neoadjuvant combined modality treatment for locally advanced
rectal cancer: first results of the German rectal cancer study (CAO/ARO/AIO-94).
Int J Radiat Oncol Biol Phys.
2003;
57
S124-S125
- 51
Sauer R, Fietkau R, Wittekind C, Rodel C, Martus P, Hohenberger W, Tschmelitsch J,
Sabitzer H, Karstens J H, Becker H, Hess C, Raab R.
Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer:
the German trial CAO/ARO/AIO-94.
Colorectal Dis.
2003;
5
406-415
- 52
Tveit K M, Guldvog I, Hagen S, Trondsen E, Harbitz T, Nygaard K, Nilsen J B, Wist E,
Hannisdal E. Norwegian Adjuvant Rectal Cancer Project Group .
Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled
5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal
cancer.
Br J Surg.
1997;
84
1130-1135
- 53
Zimmermann F, Molls M.
In Process Citation.
Chirurg.
2003;
74
887-896
Prof. Dr. med. Dr. h. c. M. W. Büchler
Chirurgische Universitätsklinik Heidelberg, Ruprecht-Karls-Universität Heidelberg
Im Neuenheimer Feld 110
69120 Heidelberg
Phone: 06221/566201
Email: markus_buechler@med.uni-heidelberg.de